Tag: Ajay Tandon

July 7, 2017

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it...
August 18, 2016

SeeThruEquity Issues Update on BioSig Technologies Highlighting Companys Technology Being Featured in Mayo Clinic Research

NEW YORK, NY / ACCESSWIRE / August 18, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm...
July 27, 2016

SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85

Q BioMed Inc. (OTCQB:QBIO) is focused on identifying, acquiring and licensing attractive biomedical assets from small private companies and academia,...
July 20, 2016

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. Highlighting Recent Uplisting to Nasdaq

NEW YORK, NY / ACCESSWIRE / July 20, 2016 / SeeThruEquity, a leading New York City based independent equity research...
April 14, 2016

SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Partnership with MD Anderson

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public...
November 19, 2014

SeeThruEquity Initiates Coverage of Lomiko Metals With Target Price of C$0.19

Independent equity research and corporate access firm SeeThruEquity has initiated coverage on Lomiko Metals Inc. (TSXV:LMR,OTCQX:LMRMF), with a price target...